Table 1.
Characteristics for Participants Who Were Invited and Responded to the Survey
| Characteristics | Participants | Breast | Cervical | Colorectal |
|---|---|---|---|---|
| (n = 241) | (n = 66) | (n = 79) | (n = 96) | |
| Age, median (q1, q3), years | 55 (42, 64) | 54 (47, 59) | 36 (33, 45) | 63 (58, 70) |
| Sex | ||||
| Female | 192 (79.7%) | 66 (100.0%) | 79 (100.0%) | 47 (49.0%) |
| Male | 49 (20.3%) | 0 (0.0%) | 0 (0.0%) | 49 (51.0%) |
| Race* | ||||
| Asian | 5 (2.1%) | 2 (3.0%) | 3 (3.8%) | 0 (0.0%) |
| Black or African American | 23 (9.5%) | 9 (13.6%) | 9 (11.4%) | 5 (5.2%) |
| Other | 16 (6.6%) | 2 (3.0%) | 9 (11.4%) | 5 (5.2%) |
| White | 194 (80.5%) | 52 (78.8%) | 57 (72.2%) | 85 (88.5%) |
| Ethnicity, Hispanic or Latino | 19 (7.9%) | 5 (7.6%) | 9 (11.4%) | 5 (5.2%) |
| Primary language Spanish | 6 (2.5%) | 2 (3.0%) | 3 (3.8%) | 1 (1.0%) |
| Marital status, married/life partner | 117 (48.5%) | 40 (60.6%) | 19 (24.1%) | 58 (60.4%) |
| Primary insurance | ||||
| Commercial | 154 (63.9%) | 45 (68.2%) | 55 (69.6%) | 54 (56.2%) |
| Medicare | 44 (18.3%) | 8 (12.1%) | 1 (1.3%) | 35 (36.5%) |
| Dual/Medicaid | 41 (17%) | 13 (19.7%) | 22 (27.8%) | 6 (6.2%) |
| Other/uninsured/unknown | 2 (0.8%) | 0 (0.0%) | 1 (1.3%) | 1 (1.0%) |
| Charlson score† | ||||
| 0 | 136 (56.4%) | 38 (57.6%) | 56 (70.9%) | 42 (43.8%) |
| 1 | 50 (20.7%) | 13 (19.7%) | 12 (15.2%) | 25 (26.0%) |
| 2 + | 55 (22.8%) | 15 (22.7%) | 11 (13.9%) | 29 (30.2%) |
| Severity of screening test abnormality‡ | ||||
| Low | 125 (51.9%) | 60 (90.9%) | 5 ( 6.3%) | 60 (62.5%) |
| Moderate | 71 (29.5%) | 6 ( 9.1%) | 36 (45.6%) | 29 (30.2%) |
| High | 45 (18.7%) | 0 ( 0.0%) | 38 (48.1%) | 7 (7.3%) |
| Primary care visit in past year§ | 171 (71%) | 45 (68.2%) | 51 (64.6%) | 75 (78.1%) |
| Completed 120-day recommended follow-up | 118 (49%) | 42 (63.6%) | 33 (41.8%) | 43 (44.8%) |
Values presented are median (q1, q3), or numbers (%)
*Race and ethnicity description: Patient demographic variables including gender, race, ethnicity, and marital status were patient self-reported in open-ended questions collected as part of routine care during patient registration
†Charlson scores by calculating it from diagnosis codes (ICD-10) pulled for dates 2 years prior to the patient’s enrollment.18
‡Risk of the screening abnormality was based on guidelines or specialist consensus. For example, a BIRADs 3 mammogram was considered low risk, a BIRADs 4 was considered medium risk, and a BIRADs 5 was considered high risk.14
§Visit occurring in same health system as testing